Sign up to our newsletter Subscribe
Valuing Health at the End of Life: An Exploratory Preference Elicitation Study

Sign up to our newsletter Subscribe
The WHO lists AMR in the top 10 global health threats but new antibiotic development is not keeping pace with the emergence of resistant pathogens. Novel ways to structure the market are being explored which incentivise developers and give healthcare systems new tools to fight AMR.
An error has occurred, please try again later.